iDNA Genomics Public (CYS:IDNA) Preferred Dividends : €0.00 Mil (TTM As of . 20)

View and export this data going back to 2021. Start your Free Trial

What is iDNA Genomics Public Preferred Dividends?

Preferred dividend is a dividend that is accrued and paid on a company's preferred shares. iDNA Genomics Public's preferred dividends for the six months ended in . 20 was €0.00 Mil. Its preferred dividends for the trailing twelve months (TTM) ended in . 20 was €0.00 Mil.

iDNA Genomics Public Preferred Dividends Historical Data

The historical data trend for iDNA Genomics Public's Preferred Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

iDNA Genomics Public Preferred Dividends Chart

iDNA Genomics Public Annual Data

Trend

Preferred Dividends

iDNA Genomics Public Semi-Annual Data

Preferred Dividends

iDNA Genomics Public Preferred Dividends Calculation

A dividend that is accrued and paid on a company's preferred shares.

iDNA Genomics Public (CYS:IDNA) Preferred Dividends Explanation

In the event that a company is unable to pay all dividends, claims to preferred dividends take precedence over claims to dividends that are paid on common shares.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Preferred Dividends for the trailing twelve months (TTM) ended in . 20 was €0.00 Mil.

iDNA Genomics Public Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » iDNA Genomics Public Ltd (CYS:IDNA) » Definitions » Preferred Dividends

Comparable Companies

Traded in Other Exchanges

N/A

Address

Evrota 25- 27, Kifissia, GRC, 145 64

Website

https://www.idnagenomics.com

iDNA Genomics Public Ltd is engaged in performing precision medicine and genetic analysis (DNA Tests). Its focus is on developing and providing Genetic Testing Analysis both in Medical and Direct-To-Consumer Genomics sectors, with research activity through cooperation with universities in Greece and abroad.